[Clinical characteristics and disease course in patients treated with efalizumab following suspension of marketing authorization by the European medicines agency: a multicenter observational study].
| Image |  |
|---|---|
| Description | scientific article published on 29 April 2011 |
| Author/s |
author: Eduardo Fonseca José Luis López Estebaranz Luis Puig |
| Publication date | April 29, 2011 |
| Language | Spanish |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |